Patents by Inventor Haijing Du

Haijing Du has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240327517
    Abstract: Provided is a CD8? binding polypeptide. The CD8? binding polypeptide contains at least one variable domain, and compared with an amino acid sequence as represented by SEQ ID NO:1, the amino acid sequence of the variable domain has substitutions, deletions or additions of one or several amino acids. Further provided are a composition containing the CD8? binding polypeptide and the use thereof in the diagnosis and/or treatment of various diseases including, for example, tumors.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 3, 2024
    Applicant: SUZHOU SMARTNUCLIDE BIOPHARMACEUTICAL CO., LTD.
    Inventors: Tao XU, Chao WANG, Yanling YANG, Yan SUN, Hao QI, Haijing DU, Liyan MIAO, Yan WANG, Songbing QIN
  • Publication number: 20240209089
    Abstract: The present invention relates to the field of biological medicines. Specifically, the present invention relates to a specific CD8 binding polypeptide and use thereof.
    Type: Application
    Filed: July 20, 2021
    Publication date: June 27, 2024
    Inventors: Tao Xu, Yan Sun, Chao Wang, Hao Qi, Haijing Du, Yanling Yang
  • Publication number: 20210253709
    Abstract: The invention relates to the field of biomedicine. Specifically, the invention relates to a specific PD-L1 binding polypeptide and uses thereof in particular, uses m detecting and/or diagnosing PD-L1 related diseases such as cancers.
    Type: Application
    Filed: December 29, 2020
    Publication date: August 19, 2021
    Applicant: Suzhou Smartnuclide Biopharmaceutical Co., Ltd.
    Inventors: Tao Xu, Yan Sun, Hao Qi, Haijing Du, Tingting Hu, Yanling Yang, Fangfang Li, Qi Zhao, Songbing Qin